Chris Britten

Chris Britten

Chairman en N4 PHARMA PLC .

Fortuna: - $ al 31/03/2024

Health Technology
Commercial Services
Finance

Perfil

Chris Britten is currently the Non-executive Chairman at N4 Pharma Plc since 2019.
He also holds the position of Senior Vice President-Merges & Acquisitions at Advanz Pharma Corp.
Ltd., Head-Mergers & Acquisitions at Neuraxpharm UK Ltd., and Operations Manager at Avenue Machinery Corp.
In the past, Dr. Britten served as a Non-Executive Director at Phico Therapeutics Ltd., Director-Life Sciences at Deloitte LLP (United Kingdom), Managing Director at Torreya Partners (Europe) LLP, Global Head-Mergers & Acquisitions at Sandoz AG, and Head-Business Development at Sanofi Pasteur MSD SNC.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/12/2022 0 ( -.--% ) - $ 31/03/2024

Cargos activos de Chris Britten

EmpresasCargoInicio
N4 PHARMA PLC Chairman 01/08/2023
ADVANZ PHARMA CORP. LIMITED Corporate Officer/Principal -
Neuraxpharm UK Ltd. Corporate Officer/Principal -
Chief Operating Officer -
Todos los cargos activos de Chris Britten

Antiguos cargos conocidos de Chris Britten.

EmpresasCargoFin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
Ver el detalle de la experiencia de Chris Britten.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Chris Britten.

Relaciones

18

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
N4 PHARMA PLC

Health Technology

Empresas privadas8

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Finance

Neuraxpharm UK Ltd.

Distribution Services

Ver las conexiones de la empresa